Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Tuberculosis (Edinb) ; 91(2): 140-5, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21251883

RESUMO

The role of Th2 cytokines and Th2-associated chemokines in tuberculosis (TB) remains controversial, though in Mexico a polymorphism causing increased production of CCL2 is a risk factor. We studied levels of the Th2-associated chemokines CCL2 and CCL18, circulating soluble IL-4 receptors (sIL-4R), IL-4 and the inhibitory splice variant of IL-4 (IL-4δ2) in a cohort of patients with pulmonary TB and their healthy contacts. These were followed for 2 years during which time 10 contacts developed pulmonary TB. Results were compared with measurements made in renal and meningeal TB, and in disease controls with bacterial pneumonias or Dengue fever that have large Th2 components. In these disease controls both chemokines were significantly raised. They were also very significantly raised in all forms of TB, irrespective of age or disease site. Levels of CCL18 were raised least in meningeal TB, and most in pulmonary patients with long histories, when levels were similar to those in disease controls. Levels of CCL2, although also raised in all three forms of TB, were negatively correlated with CCL18. We found that levels of sIL-4R were strikingly reduced in all forms of TB, particularly meningeal. Contacts who progressed could not be distinguished from contacts who remained healthy at 2 years in terms of IL-4, sIL-4R, CCL2 or CCL18. However contacts had raised expression of IL-4δ2 as previously found. These results indicate vigorous and previously unrecorded activity within the Th2 axis, and further investigation is warranted.


Assuntos
Quimiocinas/sangue , Receptores de Interleucina-4/sangue , Tuberculose/imunologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Quimiocina CCL2/sangue , Quimiocinas CC/sangue , Criança , Pré-Escolar , Progressão da Doença , Ensaio de Imunoadsorção Enzimática/métodos , Feminino , Seguimentos , Humanos , Interleucina-4/sangue , Masculino , Pessoa de Meia-Idade , Pneumonia Bacteriana/imunologia , Tuberculose Meníngea/imunologia , Tuberculose Pulmonar/imunologia , Tuberculose Pulmonar/transmissão , Tuberculose Renal/imunologia , Adulto Jovem
2.
J Infect Dis ; 191(2): 299-306, 2005 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-15609241

RESUMO

BALB/c mice with pulmonary tuberculosis develop a T helper cell type 1 response that peaks at 3 weeks, temporarily controlling bacterial growth. Then bacterial proliferation recommences, accompanied by increasing interleukin (IL)-4 levels and decreasing interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, and inducible nitric oxide synthase (iNOS) levels. These changes mimic those in the human disease. In a previous study, administration of dehydroepiandrosterone (DHEA) beginning on day 60 after infection reversed these changes and protected the mice. However, DHEA is suboptimal for human use, partly because it is readily metabolized into sex steroids. 16alpha-Bromoepiandrosterone (EpiBr; 16alpha -bromo-5alpha -androstan-3beta-ol-17-one) is a synthetic adrenal steroid derivative that does not enter sex steroid pathways. In the present study, when tuberculous BALB/c mice were treated with EpiBr 3 times/week beginning on day 60, inhibition of bacterial proliferation and increased expression of TNF-alpha, IFN-gamma, and iNOS were observed, although decreased expression of IL-4 was also observed. Moreover, when given as an adjunct to conventional chemotherapy, EpiBr enhanced bacterial clearance. Trials for the use of EpiBr in the treatment of human tuberculosis are now justified.


Assuntos
Adjuvantes Imunológicos/farmacologia , Androsterona/análogos & derivados , Androsterona/farmacologia , Quimioterapia Adjuvante , Células Th1/efeitos dos fármacos , Tuberculose Pulmonar/imunologia , Adjuvantes Imunológicos/farmacocinética , Adjuvantes Imunológicos/urina , Animais , Ativação Linfocitária/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Mycobacterium tuberculosis/imunologia , Células Th1/imunologia , Tuberculose Pulmonar/metabolismo , Tuberculose Pulmonar/patologia , Fator de Necrose Tumoral alfa/imunologia
5.
Rev. bras. reumatol ; 33(6): 211-5, nov.-dez. 1993.
Artigo em Inglês | LILACS | ID: lil-169283
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA